Vijay Yajnik

Internal Medicine

165 Cambridge St Fl 9
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Advancing Equity and Patient Partnership in Clinical Trials for Inflammatory Bowel Disease: A Model for Inclusive Trial Design.

Advancing Equity and Patient Partnership in Clinical Trials for Inflammatory Bowel Disease: A Model for Inclusive Trial Design.

Journal: Clinical and experimental gastroenterology

Published: March 03, 2026

Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis.

Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis.

Journal: Science immunology

Published: February 06, 2026

Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis.

Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis.

Journal: Science immunology

Published: April 19, 2024

Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study.

Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study.

Journal: Journal of clinical pharmacology

Published: April 12, 2024

ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.

ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 25, 2023

Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis.

Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis.

Journal: bioRxiv : the preprint server for biology

Published: January 30, 2023

DOCK4 Regulation of Rho GTPases Mediates Pulmonary Vascular Barrier Function.

DOCK4 Regulation of Rho GTPases Mediates Pulmonary Vascular Barrier Function.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 28, 2022

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.

Journal: Microbiome

Published: April 27, 2021

Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.

Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.

Journal: Inflammatory bowel diseases

Published: February 28, 2021

Novel Associations Between Genome-Wide Single Nucleotide Polymorphisms and MR Enterography Features in Crohn's Disease Patients.

Novel Associations Between Genome-Wide Single Nucleotide Polymorphisms and MR Enterography Features in Crohn's Disease Patients.

Journal: Journal of magnetic resonance imaging : JMRI

Published: February 12, 2020

Challenges in IBD Research: Novel Technologies.

Challenges in IBD Research: Novel Technologies.

Journal: Inflammatory bowel diseases

Published: March 29, 2019

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis.

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis.

Journal: Crohn's & colitis 360

Published: March 28, 2019

Showing 1-12 of 75

Last Updated: 09/26/2026